"Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system" by Noor Naffakh

Selected Works of Anthony DeFranco, MD, FACC

Article

Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system

Journal of clinical oncology

Noor Naffakh
Michael Williams, Advocate Aurora Health
Priyam Patel, Advocate Aurora Health
Rachel Pedersen, Advocate Aurora Health
Michael Peterson, Advocate Aurora Health
Anthony DeFranco, Advocate Aurora Health
Stephen Medlin
Sherjeel Sana, Advocate Aurora Health
Zartash Gul, Advocate Aurora Health

Link

Scholarly Activity Date

6-1-2023

Type

Abstract

Citation Information

Williams M, Patel P, Pedersen R, et al. Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system. Journal of Clinical Oncology. 2023;41(16_suppl):e19074-e19074. doi:10.1200/JCO.2023.41.16_suppl.e19074